ArticleAnnals of the rheumatic diseases2014

IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab.

Yoshiya Tanaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.